Cholestatic Liver Disease
📧 Sign up to get email alerts when something new happens for Cholestatic Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: MRX-800: A Long-Term Safety Study of Maralixibat in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat Study [Phase 2]
A long-term safety study report for MRX-800 (maralixibat) in cholestatic liver disease, including participants who previously took part in a…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS). [Phase 2]
Phase 2 trial evaluating the safety and tolerability of maralixibat in infant participants with progressive familial intrahepatic cholestasi…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Hepatic Impairment, Cholestatic Liver Disease, & NASH with Advanced Fibrosis & Normal Hepatic Function [Phase 1]
Phase 1 trial by Zydus Therapeutics evaluating hepatic impairment, cholestatic liver disease, and nonalcoholic steatohepatitis with advanced…
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Probiotics in Pediatric Chronic Cholestasis [Phase 2, Phase 3]
A clinical trial update on probiotics for pediatric cholestatic liver disease, currently in Phase 2 and Phase 3.